Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 3 (2007), Issue 10 (October)

1. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
   Gynecol Oncol, 107(1): 99-106. [Abstract] [Full-text]
2. Magnetic resonance imaging of bone marrow in oncology, Part 2.
   Skeletal Radiol, 36(11): 1017-27. [Abstract] [Full-text]
3. Place and provision of palliative care for children with progressive cancer: a study by the Paediatric Oncology Nurses' Forum/United Kingdom Children's Cancer Study Group Palliative Care Working Group.
   J Clin Oncol, 25(28): 4472-6. [Abstract] [Full-text]
4. Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study.
   J Clin Oncol, 25(28): 4466-71. [Abstract] [Full-text]
5. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.
   J Clin Oncol, 25(28): 4379-86. [Abstract] [Full-text]
6. Educating medical students about radiation oncology: initial results of the oncology education initiative.
   J Am Coll Radiol, 4(10): 711-5. [Abstract] [Full-text]
7. Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice.
   J Am Geriatr Soc, 55(10): 1604-8. [Abstract] [Full-text]
8. Extraskeletal osteosarcoma in Japan: multiinstitutional study of 20 patients from the Japanese Musculoskeletal Oncology Group.
   J Orthop Sci, 12(5): 424-9. [Abstract] [Full-text]
9. The sentinel node biopsy under local anesthesia in breast cancer: Advantages and problems, how the technique influenced the activity of a breast surgery department; update from the European Institute of Oncology with more than 1000 cases.
   Breast, 16(5): 527-32. [Abstract] [Full-text]
10. Tests of association under misclassification: application to histological sampling in oncology.
    Stat Med, 26(26): 4808-16. [Abstract] [Full-text]
11. PET/CT in oncology: for which tumours is it the reference standard?
    Cancer Imaging, 7: S77-87. [Abstract] [Full-text]
12. Factors influencing complementary and alternative medicine use in a multisite pediatric oncology practice.
    J Pediatr Hematol Oncol, 29(10): 705-8. [Abstract] [Full-text]
13. The influence of mentorship on research productivity in oncology.
    Am J Clin Oncol, 30(5): 549-55. [Abstract] [Full-text]
14. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Semin Nucl Med, 37(6): 400-19. [Abstract] [Full-text]
15. Pitfalls of the application of microdialysis in clinical oncology: controversial findings with docetaxel.
    J Pharm Biomed Anal, 45(2): 288-94. [Abstract] [Full-text]
16. Outbreak of Burkholderia cepacia bloodstream infection at an outpatient hematology and oncology practice.
    Infect Control Hosp Epidemiol, 28(11): 1311-3. [Abstract] [Full-text]
17. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    J Clin Oncol, 25(29): 4642-7. [Abstract] [Full-text]
18. Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.
    J Clin Oncol, 25(29): 4622-7. [Abstract] [Full-text]
19. A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.
    Support Care Cancer, 15(11): 1285-91. [Abstract] [Full-text]
20. Elisabeth Pauline Pickett (1918-): opening the door for women in urological oncology.
    J Urol, 178(5): 1875-7. [Abstract] [Full-text]
21. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916.
    J Urol, 178(5): 1946-51; discussion 1951. [Abstract] [Full-text]
22. Comprehensive Geriatric assessment and its clinical impact in oncology.
    Eur J Cancer, 43(15): 2161-9. [Abstract] [Full-text]
23. Molecular and cellular biomarkers for angiogenesis in clinical oncology.
    Drug Discov Today, 12(19): 806-12. [Abstract] [Full-text]
24. Career Satisfaction, Practice Patterns and Burnout among Surgical Oncologists: Report on the Quality of Life of Members of the Society of Surgical Oncology.
    Ann Surg Oncol, 14(11): 3043-53. [Abstract] [Full-text]
25. Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709.
    Arch Otolaryngol Head Neck Surg, 133(10): 1044-50. [Abstract] [Full-text]
26. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
    J Clin Oncol, 25(30): 4800-5. [Abstract] [Full-text]
27. Need for a paradigm shift in cancer prevention and clinical oncology.
    Expert Rev Anticancer Ther, 7(10): 1363-7. [Abstract] [Full-text]
28. Secondary pseudotumor cerebri in pediatric oncology and hematology: an unpredictable condition of varying etiology.
    Pediatr Blood Cancer, 49(7): 1029-33. [Abstract] [Full-text]
29. Literature Review: Health-related Quality of Life Measurement in Pediatric Oncology: Hearing the Voices of the Children.
    J Pediatr Psychol, 32(9): 1151-63. [Abstract] [Full-text]
30. Immune response to conjugated meningococcal C vaccine in pediatric oncology patients.
    Pediatr Blood Cancer, 49(7): 918-23. [Abstract] [Full-text]
31. Lessons in pediatric neuropsycho-oncology: what we have learned since johnny gunther.
    J Pediatr Psychol, 32(9): 1029-37. [Abstract] [Full-text]
32. Patient-reported Outcomes in End-of-Life Research in Pediatric Oncology.
    J Pediatr Psychol, 32(9): 1079-88. [Abstract] [Full-text]
33. Depressive symptoms and SSRI use in pediatric oncology patients.
    Pediatr Blood Cancer, 49(7): 881-7. [Abstract] [Full-text]
34. Evidence-based Assessment, Intervention and Psychosocial Care in Pediatric Oncology: A Blueprint for Comprehensive Services Across Treatment.
    J Pediatr Psychol, 32(9): 1099-110. [Abstract] [Full-text]
35. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
    Pediatr Blood Cancer, 49(7): 894-900. [Abstract] [Full-text]
36. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Radiother Oncol, 85(1): 156-70. [Abstract] [Full-text]
37. A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: A Gynecologic Oncology Group study.
    Gynecol Oncol, 107(2): 274-9. [Abstract] [Full-text]
38. Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
    Gynecol Oncol, 107(2): 260-5. [Abstract] [Full-text]
39. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.
    Gynecol Oncol, 107(2): 177-85. [Abstract] [Full-text]
40. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.
    J Neurooncol, 85(2): 133-48. [Abstract] [Full-text]
41. Comparative oncology today.
    Vet Clin North Am Small Anim Pract, 37(6): 1023-32. [Abstract] [Full-text]
42. Communicating with oncology clients.
    Vet Clin North Am Small Anim Pract, 37(6): 1013-22. [Abstract] [Full-text]
43. Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome: a report from the Children's Oncology Group.
    Cancer, 110(9): 2067-74. [Abstract] [Full-text]
44. Phase I trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia including acute promyelocytic leukemia or lymphoma A collaborative study of The Pediatric Oncology Branch, National Cancer Institute and the Children's Oncology Group.
    Blood. [Abstract] [Full-text]
45. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
    Oncologist, 12(10): 1215-24. [Abstract] [Full-text]
46. Keeping patients safe: an interventional hand hygiene study at an oncology center.
    Clin J Oncol Nurs, 11(5): 643-6. [Abstract] [Full-text]
47. A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG).
    Int J Radiat Oncol Biol Phys, 69(4): 1181-6. [Abstract] [Full-text]
48. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
    Int J Radiat Oncol Biol Phys, 69(4): 1008-17. [Abstract] [Full-text]
49. Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.
    J Clin Oncol, 25(31): 4922-8. [Abstract] [Full-text]
50. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    J Clin Oncol, 25(31): 4909-13. [Abstract] [Full-text]
51. Fatty acid synthase inhibitors: new directions for oncology.
    Expert Opin Investig Drugs, 16(11): 1817-29. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.